Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $15,645.08 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 21,142 shares of the firm’s stock in a transaction that occurred on Wednesday, October 23rd. The shares were acquired at an average price of $0.74 per share, for a total transaction of $15,645.08. Following the completion of the transaction, the chief executive officer now owns 14,794,794 shares in the company, valued at $10,948,147.56. The trade was a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.

Retractable Technologies Stock Down 1.0 %

Shares of RVP opened at $0.73 on Friday. The firm has a market capitalization of $21.93 million, a price-to-earnings ratio of -2.82 and a beta of 2.06. Retractable Technologies, Inc. has a 52 week low of $0.71 and a 52 week high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The business’s fifty day moving average price is $0.85 and its two-hundred day moving average price is $1.00.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on Retractable Technologies in a research report on Friday, October 18th. They issued a “hold” rating on the stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.